Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline for Cannabis Use Disorder
NCT02892110Phase 2Completed
- Sponsor
- Medical University of South Carolina
- Start
- Feb 2017
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in cannabis use disorder (CUD) comparing Varenicline with Placebo (2 arms). Primary endpoint: Cannabis Withdrawal Symptoms During Active Treatment. Started Feb 2017; status: completed.
02
Drugs
varenicline
03
Conditions
cannabis use disorder (CUD)
Beyond the preview
Go deeper on NCT02892110.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02892110.